A detailed history of Melqart Asset Management (Uk) LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 9,733 shares of LLY stock, worth $7.74 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
9,733
Previous 4,058 139.85%
Holding current value
$7.74 Million
Previous $3.67 Million 134.68%
% of portfolio
0.84%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $4.38 Million - $5.45 Million
5,675 Added 139.85%
9,733 $8.62 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $2.94 Million - $3.69 Million
4,058 New
4,058 $3.67 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Melqart Asset Management (Uk) LTD Portfolio

Follow Melqart Asset Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.